“The FDA’s Fast Track designation process is designed to facilitate the development and expedite the review of drug candidates to treat serious conditions and fill an unmet medical need. Immutep will now have access to more frequent interactions with the FDA to discuss efti’s development path and, if relevant criteria are met, eligibility for Rolling Review, Accelerated Approval, and Priority ReviewI”.
Important data due q4?
- Forums
- ASX - By Stock
- IMM
- Ann: Fast Track granted by US FDA for Efti in 1st line NSCLC
Ann: Fast Track granted by US FDA for Efti in 1st line NSCLC, page-13
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
|
|||||
Last
40.5¢ |
Change
0.005(1.25%) |
Mkt cap ! $581.0M |
Open | High | Low | Value | Volume |
40.0¢ | 40.5¢ | 39.8¢ | $2.331M | 5.797M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 105570 | 44.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
36.5¢ | 15099 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 105570 | 0.445 |
6 | 31659 | 0.435 |
2 | 5315 | 0.430 |
5 | 110569 | 0.425 |
1 | 3474 | 0.420 |
Price($) | Vol. | No. |
---|---|---|
0.365 | 13655 | 1 |
0.380 | 14767 | 2 |
0.385 | 25112 | 1 |
0.395 | 12405 | 2 |
0.405 | 716757 | 9 |
Last trade - 15.59pm 12/09/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |